Another study has revealed that TGM3 expression is higher in atopic dermatitis (AD) patients and is positively linked with disease severity, indicating that TGM3 is an autoallergen immune regulator that actively affected skin inflammation in AD (Su et al., 2020). This evidence concerns the gene TGM3 and atopic eczema.